Grants
Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.
FDA ▾
Applied Regulatory Science Research to Understand Factors that Affect the Safety and Efficacy of Underrepresented Populations in Oncology Therapeutic Development (U01) Clinical Trial Optional
Supporting the use of Real-World Data to Generate Real-World Evidence in Regulatory Decision-Making (U01) Clinical Trials Optional
FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
In Vivo Regional Deposition Measurements for Supporting Model Validation (U01) Clinical Trial Required
Novel approaches to support therapeutic development in ultra-rare cancers
Designing and performing a virtual bioequivalence trial for physiologically-based pharmacokinetic and other mechanism-based models
Evaluation of oral modified release drug tablet to support the approval of additional strengths
Population Pharmacokinetic Modeling of Systemic Pharmacokinetic Data to Inform Bioequivalence in Regional Lung Exposure (U01) Clinical Trial Not Allowed
Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed
Cooperative Agreement to Support Regulatory Research Related to the 2023 Prescription Drug User Fee Act
Assuring Radiation Protection (U18) Clinical Trial Not Allowed
Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Not Allowed